UpdatesPlus-IBD - Jan 2014

The January issue of UpdatesPlus-IBD is now available.  This month we feature:

• Janssen's investigational biomarker approach to guide the selection of biologics
• New Humira data
• AdCom recommendation of vedolizumab and what this may mean to clinical practice
• Novel biologic approaches including engineered bacteria and colostrum antibodies for local delivery
• Two first in class pipeline entries
• Tyrosine kinase inhibition as a novel approach to IBD

If you have yet to receive this 81 slide issue and would like to see the summary of what is included please click here